Taking as an example the model in cancer patients and a 10 mg/kg dose, a 10% increase in KD-FcRn resulted in a decrease of 8% and 4.5% in AUCtau,ss and Cmax,ss, respectively. The gene discussed is FCGRT; the disease is cancer.